[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338399-105":59,"doc-detail-338399-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comparing-the-performance-of-deoxyribonucleic-acid-methylation-analysis-and-cytology-for-detecting-cervical-precancer-research-paper","Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer - Research paper","","Primary screening for high-risk human papillomavirus (hrHPV)–positive women in China often uses cytological triage, but cytology performance varies because it depends on subjective pathologist judgment. This cross-sectional study enrolled 657 hrHPV-positive women (age 25–64) and compared sensitivity and specificity for CIN2+ and CIN3+ across triage strategies using cytology residual specimens for DNA methylation testing. Results assess PAX1 methylation and GYPC methylation alone and combined with cytology and HPV16/18.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comparing-the-performance-of-deoxyribonucleic-acid-methylation-analysis-and-cytology-for-detecting-cervical-precancer-research-paper/338399/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comparing-the-performance-of-deoxyribonucleic-acid-methylation-analysis-and-cytology-for-detecting-cervical-precancer-research-paper/338399.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study address?","Question",{"text":112,"@type":113},"It evaluates cervical cancer screening and triage for women who test positive for high-risk human papillomavirus (hrHPV) but are non-16/18 hrHPV-positive, where cytology-based triage can show inconsistent performance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants and outcomes handled in the study?",{"text":117,"@type":113},"A total of 657 hrHPV-positive women aged 25–64 underwent colposcopic biopsy after cytology triage, and cytology residual specimens were used for DNA methylation testing. Sensitivity and specificity for CIN2+ and CIN3+ were compared across triage strategies.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about PAX1 and GYPC methylation?",{"text":121,"@type":113},"PAX1 methylation (PAX1m) and GYPC methylation (GYPCm) showed AUC values exceeding 0.85 for detecting CIN2+ and demonstrated sensitivity comparable to cytology. Relative specificity for CIN2+ was higher for both methylation markers than cytology, and combined approaches with HPV16/18 further increased relative specificity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338399,1790127703,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Tao et al. BMC Cancer (2024) 24:1352  \n[https://doi.org/10.1186/s12885-024-13126-4](https://doi.org/10.1186/s12885-024-13126-4)  \nBMC Cancer  \n RESEARCH Open Access  \nComparing the performance    \nof DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population  \nHong Tao2, Fang Yu1, Li Yang1, Xiaozhu Pei2, Saiping Mao 1 and Xing Fan 1*  \nAbstract  \nBackground Primary screening for high-risk human papillomavirus (hrHPV) with cytological triage for women with non-16/18 hrHPV-positive status has become popular in China. However, cytology relies on the subjective judgment of pathologists, leading to inconsistent clinical performance.  \nMethods A total of 657 hrHPV-positive women aged 25–64 years were enrolled in this cross-sectional study. All participants underwent colposcopic biopsy after cytology triage, with cytology residual specimens undergoing DNA methylation testing. CIN2+ and CIN3+ sensitivity and specificity were compared between the different triage strategies (n=487): PAX1 methylation (PAX1m) , Glycophorin C methylation (GYPCm), cytology, and combinations between them or with HPV16/18 .  \nResults The area under the receiver operating characteristic curves (AUCs) for PAX1m and GYPCm in detecting CIN2 or worse (CIN2+) were 0.867 (95% confidence interval [CI]: 0 .796–0. 937) and 0.873 (95% CI: 0 .808–0. 938), respectively. The sensitivities of PAX1m and GYPCm were consistent with those of cytology for both CIN2+ and CIN3+ detection. The relative specificities of PAX1m and GYPCm for CIN2+ detection compared to cytology were 2.83 (95% CI: 2 .33–2.45) and 3.09 (95% CI: 2 .40–3. 98), respectively. The relative specificities of combining HPV 16/18 with PAX1m and GYPCm for CIN2+ detection compared to cytology were 3.38 (95% CI: 2 .96–3. 86) and 3.67 (95% CI: 3 .15–4. 27), respectively. Compared to low levels of DNA methylation, high levels of PAX1m and GYPCm resulted in odd ratios (ORs) of 57.66 (95% CI: 13.57–409. 12, p \u003C 0 . 001) and 23.87 (95% CI: 6 .49–115.42, p \u003C 0 . 001) for CIN3+, adjusted for HPV 16/18 and cytology results.  \nConclusions PAX1m and GYPCm demonstrated superior ability to identify cervical precancerous lesions and cervical cancer, with AUC values exceeding 0.85. For detecting CIN2+/CIN3+ in women with hrHPV-positive status, DNA  \n*Correspondence:  \nXing Fan  \n[fx13327216229@163.com](fx13327216229@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nTao et al. BMC Cancer (2024) 24:1352 Page 2 of 11  \nmethylation (combined with HPV 16/18) showed higher specificity than cytology (combined with HPV 16/18) and is a potential molecular biomarker for detecting cervical (pre)cancer.  \nKeywords PAX1 methylation, GYPC methyla","cbCaitofIAWO34Ek","https://ap.wps.com/l/cbCaitofIAWO34Ek","pdf",1341415,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Screening strategies and triage tests","[{\"question\":\"What clinical problem does the study address?\",\"answer\":\"It evaluates cervical cancer screening and triage for women who test positive for high-risk human papillomavirus (hrHPV) but are non-16/18 hrHPV-positive, where cytology-based triage can show inconsistent performance.\"},{\"question\":\"How were participants and outcomes handled in the study?\",\"answer\":\"A total of 657 hrHPV-positive women aged 25–64 underwent colposcopic biopsy after cytology triage, and cytology residual specimens were used for DNA methylation testing. Sensitivity and specificity for CIN2+ and CIN3+ were compared across triage strategies.\"},{\"question\":\"What were the key findings about PAX1 and GYPC methylation?\",\"answer\":\"PAX1 methylation (PAX1m) and GYPC methylation (GYPCm) showed AUC values exceeding 0.85 for detecting CIN2+ and demonstrated sensitivity comparable to cytology. Relative specificity for CIN2+ was higher for both methylation markers than cytology, and combined approaches with HPV16/18 further increased relative specificity.\"}]","Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer - Research paper | PDF",1790023482,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/229219d66867c70df71be3caa9b6ec83.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c69dab05fe6d84e4b9bde34d2c21f35.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b75e4b5f5eafdab086828a4fac2482dd.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdd20e7a5e5eedd4a6a260f655264558.webp",980,1301]